<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04258787</url>
  </required_header>
  <id_info>
    <org_study_id>OHSU IRB#00020108</org_study_id>
    <secondary_id>R01EY029023-01</secondary_id>
    <nct_id>NCT04258787</nct_id>
  </id_info>
  <brief_title>OCT in Fuchs' Dystrophy</brief_title>
  <official_title>Evaluating Corneal Edema in Fuchs' Endothelial Dystrophy Using Optical Coherence Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study using optical coherence tomography (OCT) technology to
      quantify corneal edema in Fuchs' endothelial dystrophy and predict refractive shift from
      resolving corneal edema after surgical treatments.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal Epithelial Edema/Haze</measure>
    <time_frame>up to 2 years</time_frame>
    <description>OCT will be used to measure corneal epithelial edema/haze (in microns) in participants with Fuchs' or PBK</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal Stromal Edema/Haze</measure>
    <time_frame>up to 2 years</time_frame>
    <description>OCT will be used to measure corneal stromal edema/haze (in microns) in participants with Fuchs' or PBK</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Fuchs Dystrophy</condition>
  <condition>Pseudophakic Bullous Keratopathy</condition>
  <arm_group>
    <arm_group_label>Group A: No Surgery Group</arm_group_label>
    <description>This group consists of adults ages 18 or older who have been diagnosed with Fuchs' dystrophy or pseudophakic bullous keratopathy but do not require surgery per standard-of-care guidelines.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: Surgery Group</arm_group_label>
    <description>This group consists of adults ages 18 or older who have been diagnosed with Fuchs' dystrophy or pseudophakic bullous keratopathy, who require Descemet's Stripping Endothelial Keratoplasty (DSAEK), Descemet's Membrane Endothelial Keratoplasty (DMEK), or Descemet's Stripping Only (DSO) surgery. All treatment decisions will be made by the attending physician based on standard-of-care guidelines. (The study does not designate a treatment modality or pay for the treatment.)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adults age 18 or older with Fuchs' or PBK
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Damaged or diseased corneal endothelium from Fuchs' or PBK

          -  Willingness to commit to required study visits

        Exclusion Criteria:

          -  Prior Endothelial Keratoplasty (EK) or any other surgery except uncomplicated cataract
             surgery

          -  Presence of a condition that increases the probability for treatment failure (e.g.,
             heavily vascularized cornea, uncontrolled uveitis)

          -  Other primary endothelial dysfunction conditions (e.g., posterior polymorphous corneal
             dystrophy and congenital hereditary corneal dystrophy, iridocorneal endothelial
             syndrome)

          -  Central sub-epithelial or stromal scarring that could impact post-operative clarity
             assessment

          -  Peripheral anterior synechiae in the angle greater than 3 clock hours

          -  Hypotony

          -  Uncontrolled glaucoma

          -  Visually significant optic nerve or macular pathology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Winston Chamberlain, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Humberto Martinez, COT</last_name>
    <phone>503-494-7712</phone>
    <email>martinhu@ohsu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Denzil Romfh, OD</last_name>
    <phone>503-494-4351</phone>
    <email>romfhd@ohsu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Humberto Martinez, COT</last_name>
      <phone>503-494-7712</phone>
      <email>martinhu@ohsu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Denzil Romfh, OD</last_name>
      <phone>503-494-4351</phone>
      <email>romfhd@ohsu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Huang, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Afshan Nanji, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Stutzman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yan Li, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 4, 2020</study_first_submitted>
  <study_first_submitted_qc>February 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2020</study_first_posted>
  <last_update_submitted>April 8, 2020</last_update_submitted>
  <last_update_submitted_qc>April 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>David Huang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Fuchs</keyword>
  <keyword>Pseudophakic Bullous Keratopathy</keyword>
  <keyword>Optical Coherence Tomography (OCT)</keyword>
  <keyword>PBK</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fuchs' Endothelial Dystrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

